Overview
Investment Type
Venture Capital
Investment Stage
Series B
Portfolio 19
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Nov 18, 2022 | Lucy Therapeutics | lucytherapeutics.com | $12.5M | United States, Massachusetts, Cambridge |
| Nov 5, 2022 | ARKUDA Therapeutics | arkudatx.com | $108M | United States, Massachusetts, Watertown |
| Nov 5, 2022 | HotSpot Therapeutics | hotspotthera.com | $210M | United States, Massachusetts, Boston |
| SutroVax | sutrovax.com | $281M | United States | |
| Vigil Neuroscience | vigilneuro.com | $255M | United States, Massachusetts, Cambridge | |
| Fusion Pharmaceuticals | fusionpharma.com | $195.91M | Canada, Ontario, Hamilton | |
| Plexium | plexium.com | $225M | United States, California, San Diego | |
| Oculis S.A. | oculis.com | $704.2M | Switzerland | |
| Akouos | akouos.com | $162.5M | United States, Massachusetts, Boston |
Show more
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 6, 2026 | Windward Bio Announces $165 Million Crossover Financing To Advance Long-Acting Immunology Pipeline | Windward Bio, a private, clinical-stage biotechnology company based in Basel, Switzerland, has announced an upsized $165 million crossover financing led by OrbiMed, with participation from RA Capital Management, Janus Henderson Investors, S... |
| May 7, 2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay City Capital, Brunnur Ventures, EarlyBird, funds managed by Tekla Cap... |
| May 7, 2021 | Oculis closes US$57 million Series C financing | |
| Jan 5, 2018 | Oculis raises CHF20 million and moves to Switzerland | |
| Jan 4, 2018 | Oculis Raises $20.3M Series B from Novartis Venture Fund | Oculis (www.oculis.com), a clinical-stage biotechnology company focused on the development of breakthrough non-invasive topical treatment for back-of-the-eye diseases, announced it has successfully closed a Series B financing round of CHF 2... |
| May 21, 2017 | Iterum Raises $65M Series B | Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the development and commercialization of anti-infectives for patients with infectious diseases and other acute illnesses, today announced that it has clo... |
| May 21, 2017 | Domain Associates Joins $65M Series B for Iterum | Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the development and commercialization of anti-infectives for patients with infectious diseases and other acute illnesses, today announced that it has clo... |
| Mar 16, 2017 | Pivotal bioVenture Partners Closes $300M First Life Sciences Fund | San Francisco, CA-based venture capital firm Pivotal bioVenture Partners closed its first fund, at over $300m. Funded by Hong Kong based Nan Fung Group, Pivotal bioVenture Partners Fund I aims to invest in early stage biotechnology companie... |
| Fusion Pharmaceuticals Raises $105 Million In Oversubscribed Series B Financing | Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the completion of a $105 million Series B financing led by Varian and new investo... |
Reviews 0
FAQ about NFLS - Pivotal
How many startups has NFLS - Pivotal invested in?
NFLS - Pivotal has 19 portfolio companies on Parsers VC, among them Lucy Therapeutics, ARKUDA Therapeutics and HotSpot Therapeutics.
What has the press written about NFLS - Pivotal?
Parsers VC has collected 10 articles mentioning NFLS - Pivotal, among them “Windward Bio Announces $165 Million Crossover Financing To Advance Long-Acting Immunology Pipeline” (May 6, 2026) and “Oculis closes US$57 million Series C financing” (May 7, 2021).
Is NFLS - Pivotal still active?
Yes, NFLS - Pivotal is active; its latest activity on Parsers VC dates from Oct 19, 2026.